Callisto Pharmaceuticals' PIPE - II Round

Callisto Pharmaceuticals raised a round of funding on January 12, 2007.

Callisto Pharmaceuticals is a biopharmaceutical company focused on the development of drugs to treat multiple myeloma (an incurable blood cancer that invades and proliferates in bone marrow), and oste…

Articles about Callisto Pharmaceuticals' PIPE - II Round: